R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 3,125 shares at $8.58 ($27K) on 2023-01-10, disclosed to the SEC on 2023-01-11.
Scheduled sale ($27k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 995 | $8K | 31.6% |
| 2 | $8.58 | 2,130 | $18K | 68.4% |
| Total | $8.55 avg | 3,125 | $27K | 100% |
| Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |
| ADPT | SELL | 2022-04-08 | $11K | — | Filing → |